Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA041227 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA041227, RRID:AB_10795538
- Product name
- Anti-GFER
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human GFER, Gene description: growth factor, augmenter of liver regeneration, Alternative Gene Names: ALR, ERV1, HERV1, HPO1, HPO2, HSS, Validated applications: ICC, IHC, WB, Uniprot ID: P55789, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.3 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references CHCHD4 confers metabolic vulnerabilities to tumour cells through its control of the mitochondrial respiratory chain
A novel CHCHD10 mutation implicates a Mia40-dependent mitochondrial import deficit in ALS.
The Diabetes Drug Target MitoNEET Governs a Novel Trafficking Pathway to Rebuild an Fe-S Cluster into Cytosolic Aconitase/Iron Regulatory Protein 1
The Diabetes Drug Target MitoNEET Governs a Novel Trafficking Pathway to Rebuild an Fe-S Cluster into Cytosolic Aconitase/Iron Regulatory Protein 1
Thomas L, Stephen J, Esposito C, Hoer S, Antrobus R, Ahmed A, Al-Habib H, Ashcroft M
Cancer & Metabolism 2019;7(1)
Cancer & Metabolism 2019;7(1)
A novel CHCHD10 mutation implicates a Mia40-dependent mitochondrial import deficit in ALS.
Lehmer C, Schludi MH, Ransom L, Greiling J, Junghänel M, Exner N, Riemenschneider H, van der Zee J, Van Broeckhoven C, Weydt P, Heneka MT, Edbauer D
EMBO molecular medicine 2018 Jun;10(6)
EMBO molecular medicine 2018 Jun;10(6)
The Diabetes Drug Target MitoNEET Governs a Novel Trafficking Pathway to Rebuild an Fe-S Cluster into Cytosolic Aconitase/Iron Regulatory Protein 1
Ferecatu I, Gonçalves S, Golinelli-Cohen M, Clémancey M, Martelli A, Riquier S, Guittet E, Latour J, Puccio H, Drapier J, Lescop E, Bouton C
Journal of Biological Chemistry 2014;289(41):28070-28086
Journal of Biological Chemistry 2014;289(41):28070-28086
The Diabetes Drug Target MitoNEET Governs a Novel Trafficking Pathway to Rebuild an Fe-S Cluster into Cytosolic Aconitase/Iron Regulatory Protein 1
Ferecatu I, Goncalves S, Golinelli-Cohen M, Clemancey M, Martelli A, Riquier S, Guittet E, Latour J, Puccio H, Drapier J, Lescop E, Bouton C
Journal of Biological Chemistry 2014 October;289(41):28070-28086
Journal of Biological Chemistry 2014 October;289(41):28070-28086
No comments: Submit comment
No validations: Submit validation data